{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:44Z","timestamp":1792088204378,"version":"4.4.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.biochi.2025.03.002","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:46:34Z","timestamp":1741455994000},"page":"109-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Metformin's anticancer odyssey: Revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review"],"prefix":"10.1016","volume":"233","author":[{"given":"Rashmi Saxena","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talha","family":"Jawaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratap Kumar","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharma Vedika","family":"Vijaypal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogendra","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1859-7784","authenticated-orcid":false,"given":"Rohit","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ddr.21636","article-title":"A review of phenformin, metformin, and imeglimin","volume":"81","author":"Yendapally","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713038","article-title":"Insight into the molecular mechanism of diabetic kidney disease and the role of metformin in its pathogenesis","volume":"24","author":"Kleibert","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13543784.2023.2196010","article-title":"Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease","volume":"32","author":"Dihoum","year":"2023","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.biochi.2025.03.002_bib4","first-page":"1","article-title":"Metformin: update on mechanisms of action and repurposing potential","author":"Foretz","year":"2023","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib5","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"issue":"19","key":"10.1016\/j.biochi.2025.03.002_bib6","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.biochi.2025.03.002_bib7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ajem.2023.07.020","article-title":"High risk and low prevalence diseases: metformin toxicities","volume":"72","author":"Rivera","year":"2023","journal-title":"Am. J. Emerg. Med."},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/17512433.2022.2118714","article-title":"Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin","volume":"15","author":"Li","year":"2022","journal-title":"Expet Rev. Clin. Pharmacol."},{"key":"10.1016\/j.biochi.2025.03.002_bib9","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/ijms19102863","article-title":"Metformin: an old drug with new applications","volume":"19","author":"Zhou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.biochi.2025.03.002_bib11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1517\/13543784.2013.828691","article-title":"Metformin in lung cancer: rationale for a combination therapy","volume":"22","author":"Morgillo","year":"2013","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib12","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biochi.2025.03.002_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/onc.2012.181","article-title":"Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects","volume":"32","author":"Pierotti","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1470-2045(16)00006-1","article-title":"Metformin for cancer prevention: a reason for optimism","volume":"17","author":"Chan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1753-0407.2011.00119.x","article-title":"Metformin as an antitumor agent in cancer prevention and treatment","volume":"3","author":"Li","year":"2011","journal-title":"J. Diabetes"},{"key":"10.1016\/j.biochi.2025.03.002_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mehy.2018.06.029","article-title":"Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome","volume":"118","author":"Finley","year":"2018","journal-title":"Med. Hypotheses"},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1179","article-title":"Phosphoproteomic analysis of metformin signaling in colorectal cancer cells elucidates mechanism of action and potential therapeutic opportunities","volume":"13","author":"Salovska","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biochi.2025.03.002_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.biochi.2025.03.002_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biochi.2025.03.002_bib21","doi-asserted-by":"crossref","DOI":"10.1039\/C9FO01326A","article-title":"Beneficial effects of combination therapy of phloretin and metformin in streptozotocin-induced diabetic rats and improved insulin sensitivity in vitro","author":"Shen","year":"2020","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib22","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/JOE-21-0194","article-title":"Metformin as an anti-inflammatory agent: a short review","volume":"251","author":"Krist\u00f3fi","year":"2021","journal-title":"J. Endocrinol."},{"issue":"5","key":"10.1016\/j.biochi.2025.03.002_bib23","doi-asserted-by":"crossref","first-page":"C873","DOI":"10.1152\/ajpcell.00604.2020","article-title":"The intersection of metformin and inflammation","volume":"320","author":"Bharath","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biochi.2025.03.002_bib24","article-title":"Metformin exhibits anti-inflammatory effects in murine macrophages through Dicer\/miR-34a-5p and miR-125b-5p","author":"Luo","year":"2019","journal-title":"J. Diabetes Investigation"},{"key":"10.1016\/j.biochi.2025.03.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.645194","article-title":"The efficacy and potential mechanisms of metformin in the treatment of COVID-19 in the diabetics: a systematic review","volume":"12","author":"Zangiabadian","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biochi.2025.03.002_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100137","article-title":"A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19","volume":"12","author":"Kifle","year":"2021","journal-title":"Metabolism open"},{"key":"10.1016\/j.biochi.2025.03.002_bib27","article-title":"Metformin to decrease COVID-19 severity and mortality: molecular mechanisms and therapeutic potential","volume":"144","author":"Kamyshnyi","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine&pharmacotherapie"},{"key":"10.1016\/j.biochi.2025.03.002_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.645194","article-title":"The efficacy and potential mechanisms of metformin in the treatment of COVID-19 in the diabetics: a systematic review","volume":"12","author":"Zangiabadian","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biochi.2025.03.002_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.587801","article-title":"Metformin and Covid-19: focused review of mechanisms and current literature suggesting benefit","volume":"12","author":"Ibrahim","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biochi.2025.03.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112230","article-title":"Metformin to decrease COVID-19 severity and mortality: molecular mechanisms and therapeutic potential","volume":"144","author":"Kamyshnyi","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biochi.2025.03.002_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/978-3-030-20301-6_2","article-title":"Epidemiology of breast cancer in women","author":"Coughlin","year":"2019","journal-title":"Breast Cancer Metastasis and Drug Resistance: Challenges and Progress"},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.31557\/APJCP.2020.21.4.867","article-title":"A review of the epidemiology of breast cancer in asia: focus on risk factors","volume":"21","author":"Youn","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.biochi.2025.03.002_bib34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/genes10020153","article-title":"Genetic epidemiology of breast cancer in Latin America","volume":"10","author":"Zavala","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.biochi.2025.03.002_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1240098","article-title":"Global epidemiology of breast cancer based on risk factors: a systematic review","volume":"13","author":"Roheel","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib36","article-title":"Metformin in breast cancer: preclinical and clinical evidence","author":"De","year":"2019","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.breast.2019.08.003","article-title":"A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy","volume":"48","author":"Pimentel","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.biochi.2025.03.002_bib38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.breast.2019.08.003","article-title":"A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy","volume":"48","author":"Pimentel","year":"2019","journal-title":"Breast"},{"key":"10.1016\/j.biochi.2025.03.002_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2019.01.036","article-title":"The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials","volume":"141","author":"Zhang","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.biochi.2025.03.002_bib40","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.2022.6147","article-title":"Effect of metformin vs placebo on invasive disease\u2013free survival in patients with breast cancer: the MA. 32 randomized clinical trial","volume":"327","author":"Goodwin","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.biochi.2025.03.002_bib41","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/curroncol28020134","article-title":"Impact of metformin on cancer biomarkers in non-diabetic cancer patients: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Farkhondeh","year":"2021","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0598-8","article-title":"Metformin in breast cancer - an evolving mystery","volume":"17","author":"Camacho","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s10911-019-09429-z","article-title":"Metformin and breast cancer: molecular targets","author":"Faria","year":"2019","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-015-0598-8","article-title":"Metformin in breast cancer - an evolving mystery","volume":"17","author":"Camacho","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s10911-019-09429-z","article-title":"Metformin and breast cancer: molecular targets","author":"Faria","year":"2019","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.biochi.2025.03.002_bib46","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/ijms23052705","article-title":"Metformin and breast cancer: where are we now?","volume":"23","author":"Cejuela","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib47","first-page":"89","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterology Review\/Przegl\u0105dGastroenterologiczny"},{"key":"10.1016\/j.biochi.2025.03.002_bib48","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1007\/s10620-019-05690-8","article-title":"Epidemiology of colorectal cancer in average risk adults 20\u201339 Years of age: a population-based national study","volume":"64","author":"Glover","year":"2019","journal-title":"Dig. Dis. Sci."},{"issue":"21","key":"10.1016\/j.biochi.2025.03.002_bib49","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2019.07.91","article-title":"Concise update on colorectal cancer epidemiology","volume":"7","author":"Mattiuzzi","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.biochi.2025.03.002_bib50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","article-title":"Colorectal cancer epidemiology: recent trends and impact on outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.biochi.2025.03.002_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s13046-019-1495-2","article-title":"Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects","volume":"38","author":"Kamarudin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib52","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.3390\/ijms22147371","article-title":"CXCL12-CXCR4\/CXCR7 Axis in colorectal cancer: therapeutic target in preclinical and clinical studies","volume":"22","author":"Khare","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2025.03.002_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.862889","article-title":"Zebrafish Avatars of rectal cancer patients validate the radiosensitive effect of metformin","volume":"12","author":"Costa","year":"2022","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.biochi.2025.03.002_bib54","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cncr.29165","article-title":"Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population","volume":"121","author":"Sehdev","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib55","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1186\/s12885-020-07564-z","article-title":"The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial","volume":"20","author":"Higurashi","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz096","article-title":"Randomized phase II trial of exercise, metformin, or both on metabolic biomarkers in colorectal and breast cancer survivors","volume":"4","author":"Meyerhardt","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.biochi.2025.03.002_bib57","article-title":"Metformin enhances the sensitivity of colorectal cancer cells to cisplatin through ROS-mediated PI3K\/Akt signaling pathway","author":"Zhang","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.biochi.2025.03.002_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-022-04649-4","article-title":"Metformin suppresses the growth of colorectal cancer by targeting INHBA to inhibit TGF-\u03b2\/PI3K\/AKT signaling transduction","volume":"13","author":"Xiao","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib59","first-page":"1203","article-title":"Metformin attenuates cells stemness and epithelial-mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a\/\u03b2-catenin pathway","volume":"19","author":"Zhang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biochi.2025.03.002_bib60","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biocel.2019.05.004","article-title":"Metformin inhibits \u00ce2-catenin phosphorylation on Ser-552 through an AMPK\/PI3K\/Akt pathway in colorectal cancer cells","volume":"112","author":"Amable","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib63","first-page":"28","article-title":"Epidemiology, staging and management of prostate cancer","volume":"8","author":"Barsouk","year":"2020","journal-title":"Med. Sci."},{"key":"10.1016\/j.biochi.2025.03.002_bib64","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","article-title":"Epidemiology and genomics of prostate cancer in Asian men","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat. Rev. Urol."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"\u201c2022 update on prostate cancer epidemiology and risk factor- A systematic review \u201c","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biochi.2025.03.002_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41391-018-0085-2","article-title":"The anticancer potential of metformin on prostate cancer","volume":"22","author":"Zaidi","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/bco2.187","article-title":"Systematic review of antitumour efficacy and mechanism of metformin activity in prostate cancer models","volume":"4","author":"Wang","year":"2023","journal-title":"BJUI Compass"},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/CEJ.0000000000000514","article-title":"Effect of metformin on the risk of prostate cancer in patients with type 2 diabetes by considering different confounding factors","volume":"29","author":"Wang","year":"2020","journal-title":"Eur. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.biochi.2025.03.002_bib69","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.clgc.2021.08.008","article-title":"TAXOMET: a French prospective multicentric randomized phase II study of docetaxel plus metformin versus docetaxel plus placebo in metastatic castration-resistant prostate cancer","volume":"19","author":"Martin","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib70","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/s41598-018-38285-w","article-title":"The effect of metformin therapy on incidence and prognosis in prostate cancer: a systematic review and meta-analysis","volume":"9","author":"He","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.biochi.2025.03.002_bib71","article-title":"Metformin use and prostate cancer risk: a meta-analysis of cohort studies","volume":"98","author":"Feng","year":"2019","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.biochi.2025.03.002_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.2025","article-title":"Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: a nationwide population-based cohort study","author":"Kuo","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.biochi.2025.03.002_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00345-021-03858-4","article-title":"The role of metformin, statins and diet in men on active surveillance for prostate cancer","volume":"40","author":"Tiwari","year":"2022","journal-title":"World J. Urol."},{"key":"10.1016\/j.biochi.2025.03.002_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106094","article-title":"Antidiabetic medications and the risk of prostate cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"177","author":"Cui","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000872","article-title":"Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study","volume":"7","author":"Au Yeung","year":"2019","journal-title":"BMJ Open Diabetes Research & Care"},{"key":"10.1016\/j.biochi.2025.03.002_bib76","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12935-021-02043-2","article-title":"Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.biochi.2025.03.002_bib77","first-page":"4277","article-title":"Combination of metformin and paclitaxel suppresses proliferation and induces apoptosis of human prostate cancer cells via oxidative stress and targeting the mitochondria-dependent pathway","volume":"17","author":"Zhao","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biochi.2025.03.002_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41391-018-0085-2","article-title":"The anticancer potential of metformin on prostate cancer","volume":"22","author":"Zaidi","year":"2019","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.biochi.2025.03.002_bib79","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12935-021-02043-2","article-title":"Metformin exerts anti-AR-negative prostate cancer activity via AMPK\/autophagy signaling pathway","volume":"21","author":"Chen","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"44","key":"10.1016\/j.biochi.2025.03.002_bib80","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib81","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib82","first-page":"1","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"CancerLetters"},{"issue":"21","key":"10.1016\/j.biochi.2025.03.002_bib83","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.18632\/oncotarget.27586","article-title":"An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma","volume":"11","author":"Bever","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.biochi.2025.03.002_bib84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/medicina58040467","article-title":"The impact of epithelial\u2013mesenchymal transition and metformin on pancreatic cancer chemoresistance: a pathway towards individualized therapy","volume":"58","author":"Gulla","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.biochi.2025.03.002_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.32254","article-title":"Metformin and pancreatic cancer survival: real effect or immortal time bias?","author":"Wei","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib86","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/curroncol28020134","article-title":"Impact of metformin on cancer biomarkers in non-diabetic cancer patients: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Farkhondeh","year":"2021","journal-title":"Curr. Oncol."},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib87","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/pds.5550","article-title":"A systematic review and meta-analysis of observational studies of the association between the use of incretin-based therapies and the risk of pancreatic cancer","volume":"32","author":"Hidayat","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"23","key":"10.1016\/j.biochi.2025.03.002_bib88","first-page":"10283","article-title":"Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K\/Akt\/mTOR signaling pathway","volume":"23","author":"Zhou","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.biochi.2025.03.002_bib89","first-page":"10","article-title":"Metformin reduces pancreatic cancer cell proliferation and increases apoptosis through MTOR signaling pathway and its dose-effect relationship","volume":"24","author":"Zhao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.biochi.2025.03.002_bib90","first-page":"335","article-title":"Lung cancer: epidemiology and screening","volume":"102","author":"Oliver","year":"2022","journal-title":"Surg. Clin."},{"issue":"13","key":"10.1016\/j.biochi.2025.03.002_bib91","first-page":"1583","article-title":"Global burden and trends of lung cancer incidence and mortality","volume":"136","author":"Li","year":"2023","journal-title":"Chinese medical journal"},{"issue":"Supplement","key":"10.1016\/j.biochi.2025.03.002_bib92","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.4103\/ijc.IJC_52_21","article-title":"Evolving trends in lung cancer: epidemiology, diagnosis, and management","volume":"59","author":"Deshpand","year":"2022","journal-title":"Indian J. Cancer"},{"issue":"3","key":"10.1016\/j.biochi.2025.03.002_bib93","doi-asserted-by":"crossref","first-page":"220","DOI":"10.21037\/tlcr.2018.05.06","article-title":"The epidemiology of lung cancer","volume":"7","author":"de Groot","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib94","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2019.10.009","article-title":"Epidemiology of lung cancer and lung cancer screening programs in China and the United States","volume":"468","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"issue":"13","key":"10.1016\/j.biochi.2025.03.002_bib95","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.3390\/ijms22137064","article-title":"Metformin protects against radiation-induced acute effects by limiting senescence of bronchial-epithelial cells","volume":"22","author":"Hansel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"51","key":"10.1016\/j.biochi.2025.03.002_bib96","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013652","article-title":"Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum","volume":"97","author":"Wen-Xiu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.biochi.2025.03.002_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.639016","article-title":"Metformin adjunct with antineoplastic agents for the treatment of lung cancer: a meta-analysis of randomized controlled trials and observational cohort studies","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib98","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12890-023-02655-6","article-title":"Metformin induces ferroptosis through the Nrf2\/HO-1 signaling in lung cancer","volume":"23","author":"Deng","year":"2023","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.biochi.2025.03.002_bib99","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Wom. Health"},{"key":"10.1016\/j.biochi.2025.03.002_bib101","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/cancers14092230","article-title":"Worldwide burden, risk factors, and temporal trends of ovarian cancer: a global study","volume":"14","author":"Huang","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib102","doi-asserted-by":"crossref","DOI":"10.21037\/cco-20-34","article-title":"Epidemiology of ovarian cancer","volume":"9","author":"Gaona-Luviano","year":"2020","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib104","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/cco-20-34","article-title":"Epidemiology of ovarian cancer","volume":"9","author":"Gaona-Luviano","year":"2020","journal-title":"Chin. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","article-title":"Developing organoids from ovarian cancer as experimental and preclinical models","volume":"14","author":"Maenhoudt","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.biochi.2025.03.002_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gore.2019.06.003","article-title":"Checkpoint inhibitors in ovarian cancer: a review of preclinical data","volume":"29","author":"Doo","year":"2019","journal-title":"Gynecologic Oncology Reports"},{"key":"10.1016\/j.biochi.2025.03.002_bib107","article-title":"Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies","volume":"12","author":"Yi-Chao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib108","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/cells8050505","article-title":"Current status of patient-derived ovarian cancer models","volume":"8","author":"Maru","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biochi.2025.03.002_bib109","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/biomedicines9081020","article-title":"Clinical implication of metformin in relation to diabetes mellitus and ovarian cancer","volume":"9","author":"Singh","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biochi.2025.03.002_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.giec.2021.03.001","article-title":"Gastric cancer epidemiology","volume":"31","author":"Thrift","year":"2021","journal-title":"Gastrointestinal Endoscopy Clinics of North America"},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib111","first-page":"26","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Gastroenterology Review\/Przegl\u0105dGastroenterologiczny"},{"issue":"6","key":"10.1016\/j.biochi.2025.03.002_bib112","doi-asserted-by":"crossref","first-page":"695","DOI":"10.21147\/j.issn.1000-9604.2020.06.03","article-title":"Gastric cancer: epidemiology, risk factors and prevention strategies","volume":"32","author":"Yang","year":"2020","journal-title":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu"},{"key":"10.1016\/j.biochi.2025.03.002_bib113","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biochi.2025.03.002_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01308","article-title":"Epidermal growth factor receptor family and its role in gastric cancer","volume":"9","author":"Arienti","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib115","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.3390\/cancers13205216","article-title":"Molecular targets for gastric cancer treatment and future perspectives from a clinical and translational point of view","volume":"13","author":"K\u00f6rfer","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biochi.2025.03.002_bib116","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12885-019-5696-z","article-title":"Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib117","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s12094-020-02304-y","article-title":"The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"22","author":"Shuai","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib118","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819834511","article-title":"Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence","volume":"12","author":"Cheung","year":"2019","journal-title":"Therapeutic advances in gastroenterology"},{"key":"10.1016\/j.biochi.2025.03.002_bib119","article-title":"Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: a nationwide cohort study","author":"Cho","year":"2020","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.biochi.2025.03.002_bib120","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.2147\/OTT.S242298","article-title":"Metformin promotes beclin1-dependent autophagy to inhibit the progression of gastric cancer","volume":"13","author":"Liu","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"16","key":"10.1016\/j.biochi.2025.03.002_bib121","doi-asserted-by":"crossref","first-page":"8112","DOI":"10.7150\/thno.54961","article-title":"CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer","volume":"11","author":"Deng","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.biochi.2025.03.002_bib122","first-page":"1271","article-title":"Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR\/AKT signaling","volume":"54","author":"Lu","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biochi.2025.03.002_bib123","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.omto.2020.11.004","article-title":"Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways","volume":"20","author":"Guo","year":"2021","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.biochi.2025.03.002_bib124","first-page":"15","article-title":"Epidemiology of bladder","volume":"8","author":"Saginala","year":"2020","journal-title":"Cancer. Med. Sci."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib125","first-page":"7","article-title":"A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries","volume":"23","author":"Farhood","year":"2019","journal-title":"Wsp\u00f3\u0142czesnaOnkologia"},{"key":"10.1016\/j.biochi.2025.03.002_bib126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00345-018-2436-y","article-title":"Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD\u2013SIU joint consultation on bladder cancer","volume":"37","author":"Fern\u00e1ndez","year":"2019","journal-title":"World J. Urol."},{"key":"10.1016\/j.biochi.2025.03.002_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713353","article-title":"The impact of metformin on tumor-infiltrated immune cells: preclinical and clinical studies","volume":"24","author":"Abdelmoneim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biochi.2025.03.002_bib128","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.18632\/oncotarget.6933","article-title":"High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model","volume":"7","author":"Peng","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.biochi.2025.03.002_bib129","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/BLC-211653","article-title":"The effect of metformin on bladder cancer incidence and outcomes: a systematic review and meta-analysis","volume":"8","author":"van Hattum","year":"2022","journal-title":"Bladder Cancer"},{"issue":"8","key":"10.1016\/j.biochi.2025.03.002_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071583","article-title":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review","volume":"8","author":"Franciosi","year":"2013","journal-title":"PLoS One"},{"issue":"13 Apr","key":"10.1016\/j.biochi.2025.03.002_bib131","article-title":"Metformin and thymoquinone synergistically inhibit proliferation of imatinib-resistant human leukemic cells","volume":"13","author":"Glamoclija","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biochi.2025.03.002_bib132","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005719","article-title":"Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression","volume":"11","author":"Finisguerra","year":"2023","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.biochi.2025.03.002_bib133","article-title":"Anticancer mechanisms of metformin: a review of the current evidence","volume":"254","author":"Bin","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.biochi.2025.03.002_bib134","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4081\/oncol.2021.514","article-title":"Metformin - its anti-cancer effects in hematologic malignancies","volume":"15","author":"Podhorecka","year":"2021","journal-title":"Oncology reviews"},{"key":"10.1016\/j.biochi.2025.03.002_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.obmed.2020.100186","article-title":"Metformin: a review of its therapeutic efficacy and adverse effects","volume":"17","author":"Shurrab","year":"2020","journal-title":"Obesity Medicine"},{"key":"10.1016\/j.biochi.2025.03.002_bib136","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s13300-021-01058-2","article-title":"Efficacy and side effect profile of different formulations of metformin: a systematic review and meta-analysis","volume":"12","author":"Tarry-Adkins","year":"2021","journal-title":"Diabetes Ther"}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908425000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T10:10:36Z","timestamp":1747476636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908425000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":135,"alternative-id":["S0300908425000562"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2025.03.002","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin's anticancer odyssey: Revealing multifaceted mechanisms across diverse neoplastic terrains- a critical review","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2025.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}